A study to investigate Thetanix (Bacteroides thetaiotaomicron) in young people aged 16 to 18 years with stable Crohn's disease A study to investigate Thetanix (Bacteroides thetaiotaomicron) in young people aged 16 to 18 years w ...
A Phase 1 randomised, double-blind, placebo-controlled study to assess the safety and tolerability of Bacteroides thetaiotaomicron in young people aged 16 to 18 years with stable Crohn's disease. - A study of Thetanix in young people with stable Crohn's disease A Phase 1 randomised, double-blind, placebo-controlled study to assess the safety and tolerability o ...
Crohn's disease in young persons MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;System Organ Class: 10017947 - Gastrointestinal disorders ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] Crohn's disease in young persons MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: C ...
Product Name: Thetanix Product Code: B. theta INN or Proposed INN: Colony-purified Bacteroides thetaiotaomicron (B.theta) Other descriptive name: B. thetaProduct Name: Thetanix Product Code: B. theta INN or Proposed INN: Colony-purified Bacteroides thetaio ...
4D Pharma
NULL
Not Recruiting
Female: yes Male: yes
18
Human pharmacology (Phase 1): yes Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): no Human pharmacology (Phase 1): yes Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - ( ...